Alleyn Plowright PhD

Alleyn Plowright obtained his Ph.D. in organic chemistry with Professor Gerald Pattenden at the University of Nottingham in 1999 and continued with postdoctoral studies with Professor Andrew Myers at Harvard University in 2000–2001. In 2002, he joined AstraZeneca UK as a medicinal chemist working in the Oncology and then Metabolic Disease research areas. He moved to AstraZeneca, Sweden, in 2006 and in 2012 became Senior Principal Scientist, Medicinal Chemistry in the Cardiovascular and Metabolic Diseases Innovative Medicines unit. His research interests include drug design, phenotypic screening and drug discovery for cardiovascular and metabolic diseases including regenerative medicine.